Specialised Services Commissioning Committee publishes November 2018 prioritisation list

The Specialised Services Commissioning Committee (SSCC) has published the latest prioritisation list for services not commissioned through NICE or other routes in the NHS in England. The prioritisation exercise is carried out by the Clinical Priorities Advisory Group (CPAG) made up of doctors, health experts and patient representatives and the Specialised Commissioning Oversight Group (SCOG).

In this round, sufficient funding was available to provide funding for levels 1-3 of the prioritised list. These services were:

Level 1

No products

Level 2

  • Small bowel transplantation service (adults) and small bowel transplantation (children)
  • Selexipag for pulmonary arterial hypertension
  • Trientine dihydrochloride for Wilson disease

Level 3

  • Everolimus for refractory seizures associated with tuberous sclerosis complex
  • Selective internal radiation therapy (SIRT) for chemotherapy refractory / intolerant
    metastatic colorectal cancer
  • Metreleptin for congenital leptin deficiency
  • Human coagulation factor X for hereditary factor X deficiency

Sapropterin for phenylketonuria was not prioritised highly enough to fund in this round.

More information on NHS England Commissioning is available here.

Tagged with

Published on 28. December 2018 in News, News UK